The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Breast cancer (BC) is a leading global cancer with subtypes lacking effective molecular targets, leading to poor prognosis.
• The Notch signaling pathway, crucial for cell fate, is implicated in various cancers, including BC, with both tumor-promoting and suppressive roles.
• Understanding Notch signaling's role in BC immunity and angiogenesis is vital for developing novel therapies.

Purpose of the Study:

• To review the role of the Notch signaling pathway in breast cancer (BC) angiogenesis and immune response.
• To explore potential pharmacological targets within the Notch signaling pathway for BC treatment.

Main Methods:

• Literature review of studies on Notch signaling in breast cancer.
• Analysis of Notch signaling's involvement in BC-related angiogenesis and tumor immunity.
• Identification of potential therapeutic targets.

Main Results:

• Notch signaling appears to play a pro-oncogenic role in BC, influencing tumor immunity and angiogenesis.
• Aberrant Notch signaling contributes to BC pathogenesis and progression.
• The pathway's involvement in angiogenesis is critical for BC growth and metastasis.

Conclusions:

• The Notch signaling pathway is a promising target for novel breast cancer immunotherapies and anti-angiogenic treatments.
• Targeting Notch signaling may overcome therapeutic resistance in certain BC subtypes.
• Further research into Notch signaling's pharmacological targets can advance BC treatment strategies.